Global Information
회사소개 | 문의 | 비교리스트

세계의 제네릭 주사제 시장 예측(-2028년) : COVID-19의 영향, 제품 종류별, 용기 종류별, 용도별, 투여 경로별, 지역별 분석

Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Container Type, Application, and Route of Administration, and Geography

리서치사 The Insight Partners
발행일 2022년 03월 상품코드 1070738
페이지 정보 영문 217 Pages 배송안내
가격
US $ 4,550 ₩ 5,916,000 PDF (Single User License)
US $ 6,550 ₩ 8,517,000 PDF (Site License)
US $ 8,550 ₩ 11,118,000 PDF (Enterprise License)


세계의 제네릭 주사제 시장 예측(-2028년) : COVID-19의 영향, 제품 종류별, 용기 종류별, 용도별, 투여 경로별, 지역별 분석 Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Container Type, Application, and Route of Administration, and Geography
발행일 : 2022년 03월 페이지 정보 : 영문 217 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 제네릭 주사제 시장 규모는 2021년에 747억 3,000만 달러를 기록하고, 2021-2028년에 10.5%의 CAGR로 성장하여 2028년까지 1,506억 5,000만 달러에 달할 것으로 예상됩니다.

세계의 제네릭 주사제(Generic Injectables) 시장을 조사했으며, 시장 개요, 시장 성장 촉진요인·억제요인 분석, 시장 기회, COVID-19의 영향, 부문별 시장 분석, 경쟁 상황, 주요 기업 개요 등 체계적인 정보를 제공합니다.

목차

제1장 서론

제2장 중요한 포인트

제3장 조사 방법

제4장 제네릭 주사제 시장 : 시장 상황

  • 개요
  • PEST 분석
  • 전문가의 견해

제5장 제네릭 주사제 시장 : 주요 시장 역학

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 향후 동향
  • 영향 분석

제6장 제네릭 주사제 : 세계 시장 분석

  • 세계 시장 매출 예측과 분석
  • 세계 시장 매출 예측과 분석
  • 주요 기업의 시장 포지셔닝

제7장 세계의 제네릭 주사제 시장 매출과 2028년까지 예측 : 제품 종류별

  • 개요
  • 제품 종류별 시장(2021년 및 2028년)
  • 고분자 주사제
  • 소분자 주사제

제8장 세계의 제네릭 주사제 시장 매출과 2028년까지 예측 : 용기 종류별

  • 개요
  • 용기 종류별 시장(2021년 및 2028년)
  • 바이알
  • 프리믹스
  • 프리필드 시린지
  • 앰플
  • 기타

제9장 세계의 제네릭 주사제 시장 매출과 2028년까지 예측 : 용도별

  • 개요
  • 용도별 시장(2021년 및 2028년)
  • 종양학
  • 감염증
  • 심장병학
  • 당뇨병
  • 면역학
  • 기타

제10장 세계의 제네릭 주사제 시장 매출과 2028년까지 예측 : 투여 경로별

  • 개요
  • 투여 경로별 시장(2021년 및 2028년)
  • 정맥내
  • 근육내
  • 피하
  • 기타

제11장 제네릭 주사제 시장 매출과 2028년까지 예측 : 지역 분석

  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 중남미

제12장 제네릭 주사제 시장에 대한 COVID-19 팬데믹의 영향

  • 북미
  • 유럽
  • 아시아태평양
  • 중동 및 아프리카
  • 중남미

제13장 제네릭 주사제 시장 : 업계 상황

  • 개요
  • 시장 기업에 의해 행해진 성장 전략
  • 유기적 개발
  • 무기적 개발

제14장 기업 개요

  • AstraZeneca
  • Baxter International Inc.
  • Biocon
  • Fresenius SE & Co. KGaA
  • GlaxoSmithKline plc.
  • Hikma Pharmaceuticals PLC
  • Johnson and Johnson Services, Inc.
  • Lupin
  • Viatris Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.

제15장 부록

  • The Insight Partners 소개
  • 용어집
KSM 22.05.03

List Of Tables

  • Table 1. North America Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 2. North America Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 3. North America Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 4. North America Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 5. US Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 6. US Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 7. US Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 8. US Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 9. Canada Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 10. Canada Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 11. Canada Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 12. Canada Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 13. Mexico Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 14. Mexico Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 15. Mexico Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 16. Mexico Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 17. Europe Generic Injectables Market Revenue and Forecast to 2028, By Product Type (US$ Million).
  • Table 18. Europe Generic Injectables Market - Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 19. Europe Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 20. Europe Generic Injectables Market - Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 21. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
  • Table 22. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 23. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 24. Germany Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 25. France Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 26. France Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 27. France Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 28. UK Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
  • Table 29. UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 30. UK Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 31. UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 32. Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
  • Table 33. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 34. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 35. Italy Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 36. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
  • Table 37. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 38. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 39. Spain Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 40. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
  • Table 41. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
  • Table 42. Rest of Europe Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)
  • Table 43. Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • Table 44. Asia Pacific Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 45. Asia Pacific Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 46. Asia Pacific Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 47. Asia Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 48. China Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 49. China Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 50. China Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 51. China Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 52. Japan Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 53. Japan Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 54. Japan Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 55. Japan Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 56. India Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 57. India Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 58. India Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 59. India Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 60. Australia Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 61. Australia Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 62. Australia Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 63. Australia Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 64. South Korea Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 65. South Korea Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 66. South Korea Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 67. South Korea Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 68. Rest of Asia Pacific Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 69. Rest of Asia Pacific Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 70. Rest of Asia Pacific Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 71. Rest of Asia Pacific Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 72. Middle East & Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 73. Middle East & Africa Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 74. Middle East & Africa Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 75. Middle East & Africa Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 76. Saudi Arabia Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 77. Saudi Arabia Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 78. Saudi Arabia Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 79. Saudi Arabia Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 80. UAE Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 81. UAE Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 82. UAE Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 83. UAE Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 84. South Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 85. South Africa Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 86. South Africa Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 87. South Africa Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 88. Rest of Middle East & Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 89. Rest of Middle East & Africa Generic Injectables Market, by Container Type- Revenue and Forecast to 2028 (USD Million)
  • Table 90. Rest of Middle East & Africa Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 91. Rest of Middle East & Africa Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 92. South and Central America Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 93. South and Central America Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 94. South and Central America Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 95. South and Central America Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 96. Brazil Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 97. Brazil Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 98. Brazil Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 99. Brazil Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 100. Argentina Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 101. Argentina Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 102. Argentina Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 103. Argentina Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 104. Rest of South and Central America Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
  • Table 105. Rest of South and Central America Generic Injectables Market, by Container Type - Revenue and Forecast to 2028 (USD Million)
  • Table 106. Rest of South and Central America Generic Injectables Market, by Application - Revenue and Forecast to 2028 (USD Million)
  • Table 107. Rest of South and Central America Generic Injectables Market, by Route of Administration - Revenue and Forecast to 2028 (USD Million)
  • Table 108. Organic Developments Done By Companies
  • Table 109. Inorganic Developments Done By Companies
  • Table 110. Glossary of Terms, Generic Injectables Market

List Of Figures

  • Figure 1. Generic injectables Market Segmentation
  • Figure 2. Generic injectables Market, By Region
  • Figure 3. Global Generic Injectables Market Overview
  • Figure 4. Large Molecule Injectable Segment Held Largest Share of Product Type Segment in Generic injectables Market
  • Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
  • Figure 6. Generic Injectables Market, by Geography (US$ Million)
  • Figure 7. Global Generic Injectables Market- Leading Country Markets (US$ Million)
  • Figure 8. Global Generic injectables Market, Industry Landscape
  • Figure 9. North America: PEST Analysis
  • Figure 10. Europe: PEST Analysis
  • Figure 11. Asia Pacific: PEST Analysis
  • Figure 12. Middle East And Africa: PEST Analysis
  • Figure 13. South And Central America: PEST Analysis
  • Figure 14. Experts Opinion
  • Figure 15. Generic injectables Market Impact Analysis of Driver and Restraints
  • Figure 16. Global Generic injectables Market- Revenue Forecast and Analysis - 2020- 2028
  • Figure 17. Global Generic Injectables Market- Revenue Forecast and Analysis - 2021 - 2028
  • Figure 18. Market Positioning of Key Players in Global Generic injectables Market
  • Figure 19. Global Generic Injectables Market, by Product Type, 2021 & 2028 (%)
  • Figure 20. Large Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 21. Small Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 22. Global Generic Injectables Market, by Container Type, 2021 & 2028 (%)
  • Figure 23. Vials: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 24. Premix: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 25. Prefilled Syringes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 26. Ampoules: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 27. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 28. Global Generic Injectables Market, by Application, 2021 & 2028 (%)
  • Figure 29. Oncology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 30. Infectious Diseases: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 31. Cardiology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 32. Diabetes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 33. Immunology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 34. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 35. Global Generic Injectables Market, by Route of Administration, 2021 & 2028 (%)
  • Figure 36. Intravenous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 37. Intramuscular: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 38. Subcutaneous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 39. Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 40. North America: Generic Injectables Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 41. North America Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
  • Figure 42. North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
  • Figure 43. US: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 44. Canada: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 45. Mexico: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 46. Europe: Generic Injectables Market, Revenue Overview, by Country, 2021 (US$ Million)
  • Figure 47. Europe: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • Figure 48. Europe Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)
  • Figure 49. Germany Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 50. France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 51. UK: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 52. Italy: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 53. Spain: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 54. Rest of Europe: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
  • Figure 55. Asia Pacific: Generic Injectables Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 56. Asia Pacific Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
  • Figure 57. China: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 58. Japan: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 59. India: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 60. Australia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 61. South Korea: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 62. Rest of Asia Pacific: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 63. Middle East & Africa: Generic Injectables Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 64. Middle East & Africa Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
  • Figure 65. Middle East & Africa: Generic Injectables Market, by Country, 2021 & 2028 (%)
  • Figure 66. Saudi Arabia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 67. UAE: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 68. South Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 69. Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 70. South and Central America: Generic Injectables Market, by Key Country - Revenue (2021) (USD Million)
  • Figure 71. South and Central America Generic Injectables Market Revenue and Forecast to 2028 (USD Million)
  • Figure 72. South and Central America: Generic Injectables Market, by Country, 2020 & 2028 (%)
  • Figure 73. Brazil: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 74. Argentina: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 75. Rest of South and Central America: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
  • Figure 76. Impact of COVID-19 Pandemic in North America Country Markets
  • Figure 77. Impact of COVID-19 Pandemic in European Country Markets
  • Figure 78. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
  • Figure 79. Impact of COVID-19 Pandemic on Middle East & Africa Country Markets
  • Figure 80. Impact of COVID-19 Pandemic in South and Central America Country Market
  • Figure 81. Growth Strategies Done by the Companies in the Market

The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.73 billion in 2021; it is expected to grow at a CAGR of 10.5% from 2021 to 2028.

Low R&D, marketing, and manufacturing costs and high demand for affordable drugs are driving the generic injectables market growth. However, the critical inspection system for prefilled injection is hampering the generic injectables market growth.

Generic injectables are as safe and effective as innovator molecules because they are bioequivalent to their branded counterparts, but they are not patented for many reasons. These medications can be produced for commercial usage only after the patent expiration of the branded drug. As the drug molecules are similar in branded and generic formulation, no or minimal R&D cost is associated with generic injectables. The low upfront R&D costs allow drug manufacturers to sell generic injectables at lower prices. As stated by the US FDA, a single generic competitor can lead to price reductions of 30%, while five generics competing could lead to price drops of ~85%. Additionally, generic injectables saved US$ 2.2 trillion for the US healthcare system during 2009-2019. As mentioned in a report by Congressional Budget Office, the pharmaceutical industry spent US$ 83 billion on R&D in 2019. However, with generic injectables, the repetition of clinical studies is not required to demonstrate their effectiveness and safety, which contributes to their low prices.

Further, the approval process of generic medicines is faster than branded ones. As reported by the USFDA, in 2019, 107 first generic drugs and 110 complex generic drugs were approved, totaling 11% of the generic drug product approvals. Overall, in 2019, the generic drug program approved or tentatively approved 1,014 generic drug applications. Additionally, the development of a new chemical entity takes almost a decade on average, which is bypassed in the development of generic injectables. Thus, the low cost associated with generic injectables is one of the major factors attracting new players to enter the market and driving the generic injectables market.

Further, the patents of branded injectables in several regions are likely to expire in the upcoming years, offering numerous remunerative opportunities to the generic injectables manufacturers. As per a recent publication by Business Standard, patented drugs worth US$ 240 billion will lose patents globally in the coming years. In India, the shortage of branded medicines and the expiry of branded drug patents have prompted generic injectable manufacturers to introduce advanced drug delivery systems, including self-injection devices. Biological E Limited, an Indian biotechnology and biopharmaceutical company based in Hyderabad, Telangana, is gaining recognition for broadening its portfolio with the addition of 20 routine and injectable products. Thus, generic injectables companies are tapping regulated markets and exploring other markets to generate incomes and establish stable revenue streams. Additionally, manufacturers in the generic injectables market are becoming future-ready by maintaining adequate supply chains to prevent vulnerabilities, similar to those caused by the COVID-19 outbreak. Zydus Cadila is significantly reducing the price of its generic version of remdesivir, namely Remdac. Thus, the nearing expiry of patent validity of branded drugs is likely to provide significant opportunities to generic drug manufacturers, including the companies offering generic injectables.

Based on product type, the generic injectables market is segmented into large molecule injectables and small molecule injectables. In 2021, the large molecule injectables segment accounted for a greater market share. The market position of this segment is credited to a surge in the adoption of biologics in the healthcare sector, and the progress of monoclonal antibody and antibody-drug conjugates (ADCs) into the drug development.

The global generic injectables market, based on container type, has been categorized into vials, premix, prefilled syringes, ampoules, and others. The vials segment is likely to dominate the market in 2021. The rise in health awareness on the back of the growth in the detection of new life-threatening diseases is driving the growth of vial market segment during the forecast period.

The global generic injectables market, based on application, has been categorized into oncology, infectious diseases, cardiology, diabetes, immunology, and others. The oncology segment is likely to hold the largest share of the market in 2021. With the increase in the cancer incidences and rise in the launches of drugs is anticipated to drive growth of the oncology market segment. Moreover, increasing initiatives taken by the leading players across the globe, are some of the factors which is driving the growth of the overall market segment.

Based on route of administration, the global generic injectables market has been categorized into intravenous, intramuscular, subcutaneous, and others. The intravenous route of administration holds the largest market share in 2021. The growing prevalence of chronic diseases and increasing number of product launches, have resulted in fueling the demand for intravenous route of administration market segment during the forecast period.

The National Institutes of Health (NIH), National Healthcare Service (NHS), Centers for Disease Control and Prevention (CDC), Statistics Canada 2020, National Center for Biotechnology Information, National Cancer Institute, Globocan Statistics 2020, World Bank Data, American Association of Retired Person (AARP), Association for Accessible Medicines (AAM), Plastic Packaging Facts Organization, Italian National Institute of Statistics, Australian Institute of Health and Welfare, and World Health Organization (WHO) are among the major secondary sources referred to while preparing the report on the generic injectables market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the generic injectables market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global generic injectables market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.

Table Of Contents

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Generic injectables Market - By Product Type
    • 1.3.2 Global Generic injectables Market - By Container Type
    • 1.3.3 Global Generic injectables Market - By Application
    • 1.3.4 Global Generic injectables Market - By Route of Administration
    • 1.3.5 Global Generic injectables Market - By Geography

2. Key Takeaways

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Generic Injectables Market - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 Middle East And Africa PEST Analysis
    • 4.2.5 South And Central America PEST Analysis
  • 4.3 Experts Opinion

5. Generic Injectables Market - Key Market Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Low R&D, Marketing, and Manufacturing Costs
    • 5.1.2 High Demand for Affordable Drugs
  • 5.2 Market Restraints
    • 5.2.1 Critical Inspection System for Prefilled Injection
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Patent Expiry of Drugs
  • 5.4 Future Trends
    • 5.4.1 Government Support for Generic Injectables Production and Healthcare Cost Reduction
  • 5.5 Impact Analysis

6. Generic Injectables Market- Global Analysis

  • 6.1 Global Generic Injectables Market Revenue Forecast and Analysis
  • 6.2 Global Generic Injectables Market Revenue Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Global Generic Injectables Market Revenue and Forecast To 2028- by Product Type

  • 7.1 Overview
  • 7.2 Global Generic Injectables Market, By Product Type, 2021 & 2028 (%)
  • 7.3 Large Molecule Injectables
    • 7.3.1 Overview
    • 7.3.2 Large Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 7.4 Small Molecule Injectables
    • 7.4.1 Overview
    • 7.4.2 Small Molecule Injectables: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

8. Global Generic Injectables Market Revenue and Forecast To 2028- by Container Type

  • 8.1 Overview
  • 8.2 Global Generic Injectables Market, By Container Type, 2021 & 2028 (%)
  • 8.3 Vials
    • 8.3.1 Overview
    • 8.3.2 Vials: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 8.4 Premix
    • 8.4.1 Overview
    • 8.4.2 Premix: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 8.5 Prefilled Syringes
    • 8.5.1 Overview
    • 8.5.2 Prefilled Syringes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 8.6 Ampoules
    • 8.6.1 Overview
    • 8.6.2 Ampoules: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 8.7 Others
    • 8.7.1 Overview
    • 8.7.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

9. Global Generic Injectables Market Revenue and Forecast To 2028- by Application

  • 9.1 Overview
  • 9.2 Global Generic Injectables Market, By Application, 2021 & 2028 (%)
  • 9.3 Oncology
    • 9.3.1 Overview
    • 9.3.2 Oncology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 9.4 Infectious Diseases
    • 9.4.1 Overview
    • 9.4.2 Infectious Diseases: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 9.5 Cardiology
    • 9.5.1 Overview
    • 9.5.2 Cardiology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 9.6 Diabetes
    • 9.6.1 Overview
    • 9.6.2 Diabetes: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 9.7 Immunology
    • 9.7.1 Overview
    • 9.7.2 Immunology: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 9.8 Others
    • 9.8.1 Overview
    • 9.8.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

10. Global Generic Injectables Market Revenue and Forecast To 2028- by Route of Administration

  • 10.1 Overview
  • 10.2 Global Generic Injectables Market, By Route of Administration, 2021 & 2028 (%)
  • 10.3 Intravenous
    • 10.3.1 Overview
    • 10.3.2 Intravenous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 10.4 Intramuscular
    • 10.4.1 Overview
    • 10.4.2 Intramuscular: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 10.5 Subcutaneous
    • 10.5.1 Overview
    • 10.5.2 Subcutaneous: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
  • 10.6 Others
    • 10.6.1 Overview
    • 10.6.2 Others: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)

11. Generic Injectables Market Revenue and Forecast to 2028 - Geographical Analysis

  • 11.1 North America: Generic Injectables Market Revenue and Forecast to 2028
    • 11.1.1 Overview
    • 11.1.2 North America: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
    • 11.1.3 North America: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
    • 11.1.4 North America: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
    • 11.1.5 North America: Generic Injectables Market, by Application, 2019-2028 (USD Million)
    • 11.1.6 North America: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
    • 11.1.7 North America: Generic Injectables Market, by Country, 2020 & 2028 (%)
      • 11.1.7.1 US: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.1 US: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.1.2 US: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.1.7.1.3 US: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.1.7.1.4 US: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.1.7.1.5 US: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.1.7.2 Canada: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.1 Canada: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.2.2 Canada: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.1.7.2.3 Canada: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.1.7.2.4 Canada: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.1.7.2.5 Canada: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.1.7.3 Mexico: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.1 Mexico: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.1.7.3.2 Mexico: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.1.7.3.3 Mexico: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.1.7.3.4 Mexico: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.1.7.3.5 Mexico: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
  • 11.2 Europe: Generic Injectables Market
    • 11.2.1 Overview
    • 11.2.2 Europe: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.2.3 Europe: Generic Injectables Market, Revenue and Forecast to 2028, By Product Type (US$ Million)
    • 11.2.4 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
    • 11.2.5 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
    • 11.2.6 Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
    • 11.2.7 Europe: Generic Injectables Market, Revenue and Forecast to 2028, By Country (%)
      • 11.2.7.1 Germany: Generic Injectables Market -Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.1 Germany: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.1.2 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.1.3 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.1.4 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.1.5 Germany: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
      • 11.2.7.2 France: Generic Injectables Market Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.1 France: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.2.2 France: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.2.3 France: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.2.4 France: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.2.5 France: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
      • 11.2.7.3 UK: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.1 UK: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.3.2 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.3.3 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.3.4 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.3.5 UK: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
      • 11.2.7.4 Italy: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.1 Italy: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.4.2 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.4.3 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.4.4 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.4.5 Italy: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
      • 11.2.7.5 Spain: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.1 Spain: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.5.2 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.5.3 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.5.4 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.5.5 Spain: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
      • 11.2.7.6 Rest of Europe: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.1 Rest of Europe: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
        • 11.2.7.6.2 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Product Type (US$ Million)
        • 11.2.7.6.3 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Container Type (US$ Million)
        • 11.2.7.6.4 Rest of Europe: Product Type Market- Revenue and Forecast to 2028, By Application (US$ Million)
        • 11.2.7.6.5 Rest of Europe: Generic Injectables Market- Revenue and Forecast to 2028, By Route of Administration (US$ Million)
  • 11.3 Asia Pacific: Generic Injectables Market
    • 11.3.1 Overview
    • 11.3.2 Asia Pacific: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
    • 11.3.3 Asia Pacific: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
    • 11.3.4 Asia Pacific: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
    • 11.3.5 Asia Pacific: Generic Injectables Market, by Application, 2019-2028 (USD Million)
    • 11.3.6 Asia Pacific: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
    • 11.3.7 Asia Pacific: Generic Injectables Market, by Country, 2021 & 2028 (%)
      • 11.3.7.1 China: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.1.1 China: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.1.2 China: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.1.3 China: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.1.4 China: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.1.5 China: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.3.7.2 Japan: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.2.1 Japan: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.2.2 Japan: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.2.3 Japan: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.2.4 Japan: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.2.5 Japan: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.3.7.3 India: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.3.1 India: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.3.2 India: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.3.3 India: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.3.4 India: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.3.5 India: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.3.7.4 Australia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.4.1 Australia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.4.2 Australia: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.4.3 Australia: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.4.4 Australia: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.4.5 Australia: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.3.7.5 South Korea: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.5.1 South Korea: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.5.2 South Korea: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.5.3 South Korea: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.5.4 South Korea: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.5.5 South Korea: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.3.7.6 Rest of Asia Pacific: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.6.1 Rest of Asia Pacific: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.3.7.6.2 Rest of Asia Pacific: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.3.7.6.3 Rest of Asia Pacific: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.3.7.6.4 Rest of Asia Pacific: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.3.7.6.5 Rest of Asia Pacific: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
  • 11.4 Middle East and Africa: Generic Injectables Market
    • 11.4.1 Overview
    • 11.4.2 Middle East & Africa: Generic Injectables Market - Revenue and Forecast to 2028 (US$ Million)
    • 11.4.3 Middle East & Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
    • 11.4.4 Middle East & Africa: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
    • 11.4.5 Middle East & Africa: Generic Injectables Market, by Application, 2019-2028 (USD Million)
    • 11.4.6 Middle East & Africa: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
    • 11.4.7 Middle East & Africa: Generic Injectables Market, by Country, 2021 & 2028 (%)
      • 11.4.7.1 Saudi Arabia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.1.1 Saudi Arabia: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.1.2 Saudi Arabia Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.1.3 Saudi Arabia: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.4.7.1.4 Saudi Arabia: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.4.7.1.5 Saudi Arabia: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.4.7.2 UAE: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.2.1 UAE: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.2.2 UAE Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.2.3 UAE: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.4.7.2.4 UAE: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.4.7.2.5 UAE: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.4.7.3 South Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.3.1 South Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.3.2 South Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.3.3 South Africa: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.4.7.3.4 South Africa: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.4.7.3.5 South Africa: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.4.7.4 Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.4.1 Rest of Middle East and Africa: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.4.2 Rest of Middle East & Africa Generic Injectables Market, by Product Type - Revenue and Forecast to 2028 (USD Million)
        • 11.4.7.4.3 Rest of Middle East & Africa: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.4.7.4.4 Rest of Middle East & Africa: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.4.7.4.5 Rest of Middle East & Africa: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
  • 11.5 South and Central America: Generic Injectables Market Revenue and Forecast to 2028
    • 11.5.1 South and Central America: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
    • 11.5.2 South and Central America: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
    • 11.5.3 South and Central America: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
    • 11.5.4 South and Central America: Generic Injectables Market, by Application, 2019-2028 (USD Million)
    • 11.5.5 South and Central America: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
    • 11.5.6 South and Central America: Generic Injectables Market, by Country, 2020 & 2028 (%)
      • 11.5.6.1 Brazil: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.1.1 Brazil: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.1.2 Brazil: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.5.6.1.3 Brazil: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.5.6.1.4 Brazil: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.5.6.1.5 Brazil: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.5.6.2 Argentina: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.2.1 Argentina: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.2.2 Argentina: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.5.6.2.3 Argentina: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.5.6.2.4 Argentina: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.5.6.2.5 Argentina: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)
      • 11.5.6.3 Rest of South and Central America: Generic Injectables Market- Revenue and Forecast to 2027 (USD Million)
        • 11.5.6.3.1 Rest of South and Central America: Generic Injectables Market - Revenue and Forecast to 2028 (USD Million)
        • 11.5.6.3.2 Rest of South and Central America: Generic Injectables Market, by Product Type, 2019-2028 (USD Million)
        • 11.5.6.3.3 Rest of South and Central America: Generic Injectables Market, by Container Type, 2019-2028 (USD Million)
        • 11.5.6.3.4 Rest of South and Central America: Generic Injectables Market, by Application, 2019-2028 (USD Million)
        • 11.5.6.3.5 Rest of South and Central America: Generic Injectables Market, by Route of Administration, 2019-2028 (USD Million)

12. Impact Of COVID-19 Pandemic on Generic Injectables Market

  • 12.1 North America: Impact Assessment of COVID-19 Pandemic
  • 12.2 Europe: Impact Assessment of COVID-19 Pandemic
  • 12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 12.4 MEA: Impact Assessment of COVID-19 Pandemic
  • 12.5 South and Central America: Impact Assessment of COVID-19 Pandemic

13. Generic Injectables Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies Done by the Companies in the Market
  • 13.3 Organic Developments
    • 13.3.1 Overview
  • 13.4 Inorganic Developments
    • 13.4.1 Overview

14. Company Profiles

  • 14.1 AstraZeneca
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Baxter International Inc.
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Biocon
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Fresenius SE & Co. KGaA
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 GlaxoSmithKline plc.
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Hikma Pharmaceuticals PLC
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Johnson and Johnson Services, Inc.
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Lupin
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 Viatris Inc.
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Merck & Co., Inc.
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Pfizer Inc.
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms
Back to Top
전화 문의
F A Q